Littlejohn Financial Services Inc. Grows Position in iShares Biotechnology ETF $IBB

Littlejohn Financial Services Inc. grew its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 62.3% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 18,765 shares of the financial services provider’s stock after buying an additional 7,202 shares during the period. iShares Biotechnology ETF makes up about 2.0% of Littlejohn Financial Services Inc.’s holdings, making the stock its 13th biggest holding. Littlejohn Financial Services Inc.’s holdings in iShares Biotechnology ETF were worth $2,709,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds also recently made changes to their positions in IBB. SG Americas Securities LLC increased its position in shares of iShares Biotechnology ETF by 96.3% in the third quarter. SG Americas Securities LLC now owns 28,569 shares of the financial services provider’s stock valued at $4,125,000 after acquiring an additional 14,016 shares during the period. Viewpoint Capital Management LLC grew its stake in shares of iShares Biotechnology ETF by 1,532.1% in the third quarter. Viewpoint Capital Management LLC now owns 12,730 shares of the financial services provider’s stock worth $1,838,000 after purchasing an additional 11,950 shares during the last quarter. Bronte Capital Management Pty Ltd. increased its stake in shares of iShares Biotechnology ETF by 12.6% during the second quarter. Bronte Capital Management Pty Ltd. now owns 295,346 shares of the financial services provider’s stock valued at $37,000 after buying an additional 32,947 shares during the period. Employees Retirement System of Texas bought a new position in shares of iShares Biotechnology ETF during the second quarter valued at approximately $25,049,000. Finally, D.A. Davidson & CO. lifted its stake in iShares Biotechnology ETF by 181.0% in the third quarter. D.A. Davidson & CO. now owns 13,701 shares of the financial services provider’s stock worth $1,978,000 after acquiring an additional 8,825 shares during the period. 62.45% of the stock is owned by institutional investors.

iShares Biotechnology ETF Stock Performance

Shares of NASDAQ IBB opened at $172.83 on Thursday. The firm has a fifty day simple moving average of $169.01 and a two-hundred day simple moving average of $150.95. iShares Biotechnology ETF has a 12 month low of $107.43 and a 12 month high of $179.64.

iShares Biotechnology ETF Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, December 19th. Shareholders of record on Tuesday, December 16th were issued a $0.1831 dividend. This represents a $0.73 annualized dividend and a yield of 0.4%. This is a boost from iShares Biotechnology ETF’s previous quarterly dividend of $0.08. The ex-dividend date was Tuesday, December 16th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.